Skip to the page

Data / Drug companies / Par Health USA, LLC

Par Health USA, LLC: 35 products in the FDA NDC directory, labeler code 0603

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Par Health USA, LLC (labeler code 0603) lists 35 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 33 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 17, 2022.

The request: Watch Par Health USA, LLC (FDA labeler code 0603): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0603
Products in commercial distribution
35
Packages
65
Finished drugs by generic name
14
Prescription products
33
Over the counter products
2
Controlled substance products
Schedule IV 4
Flagged as original packager
24 of 24 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
7
Earliest marketing start
December 22, 1998
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)2777.1%
Other unapproved drugs411.4%
Over the counter monograph drugs25.7%
Authorized generics (NDA)12.9%
New drug applications (NDA)12.9%

Products by type

TypeProductsShare
Prescription drugs3394.3%
Over the counter drugs25.7%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2571.4%
Tablet, film coated411.4%
Tablet, extended release25.7%
Patch12.9%
Tablet, film coated, extended release12.9%
Powder, for solution12.9%
Solution12.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Benztropine Mesylate0603-2435TabletGeneric drugs (ANDA)March 17, 2022
Benztropine Mesylate0603-2434TabletGeneric drugs (ANDA)March 17, 2022
Benztropine Mesylate0603-2433TabletGeneric drugs (ANDA)March 17, 2022
Magnesium Oxide0603-0213TabletOver the counter monograph drugsNovember 10, 2020
Potassium Chloride0603-1554Powder, for solutionNew drug applications (NDA)September 18, 2015
Magnesium Oxide0603-0209TabletOver the counter monograph drugsJuly 1, 2014
Lidocaine0603-1880PatchAuthorized generics (NDA)May 2, 2014
Felodipine0603-3583Tablet, film coated, extended releaseGeneric drugs (ANDA)December 15, 2011
Felodipine0603-3582Tablet, extended releaseGeneric drugs (ANDA)December 15, 2011
Propranolol Hydrochloride0603-5486TabletGeneric drugs (ANDA)June 21, 2010
Propranolol Hydrochloride0603-5485TabletGeneric drugs (ANDA)June 21, 2010
Propranolol Hydrochloride0603-5484TabletGeneric drugs (ANDA)June 21, 2010
Propranolol Hydrochloride0603-5483TabletGeneric drugs (ANDA)June 21, 2010
Propranolol Hydrochloride0603-5482TabletGeneric drugs (ANDA)June 21, 2010
Felodipine0603-3581Tablet, extended releaseGeneric drugs (ANDA)March 31, 2009
Baclofen0603-2407TabletGeneric drugs (ANDA)August 30, 2005
Baclofen0603-2406TabletGeneric drugs (ANDA)August 30, 2005
Dicyclomine hydrochloride0603-1161SolutionGeneric drugs (ANDA)June 23, 2005
Prednisone0603-5336TabletGeneric drugs (ANDA)December 21, 2004
Prednisone0603-5335TabletGeneric drugs (ANDA)December 21, 2004
Allopurinol0603-2116TabletGeneric drugs (ANDA)June 27, 2003
Allopurinol0603-2115TabletGeneric drugs (ANDA)June 27, 2003
Prednisone0603-5339TabletGeneric drugs (ANDA)February 12, 2003
Phenobarbital0603-5166TabletOther unapproved drugsFebruary 1, 2003
Prednisone0603-5338TabletGeneric drugs (ANDA)July 12, 2002

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.